Industries de la santé
15 Novembre 2012
NEW YORK (GBI Research), 15 November 2012 - Intravenous (IV) drips are fast evolving, as patients take their treatment in to the home, states a new report by healthcare experts GBI Research. |The new report* states that diseases such as cancer, Acquired Immune Deficiency Syndrome (AIDS) and Gastrointestinal (GI) disorders are becoming more common, due in part to a globally ageing...
Plus d'articles...
- Kwintet renforce en France sa politique commerciale pour les Grands Comptes
- Reprise de la distribution de certains médicaments exploités par les laboratoires Alkopharm/Genopharm : l’ANSM s’assure de la conformité des approvisionnements
- No evidence for 30-nm chromatin fibres in the mouse genome
- Vexim : Résultats semestriels 2012